ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate2.120.171.14-0.91
Low Estimate1.760.170.77-1.29
High Estimate2.830.171.87-0.46
Year Ago EPS-0.09-0.261.131.14
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4144
Avg. Estimate73.12M23.97M100.04M67.9M
Low Estimate71.7M23.97M98.6M62M
High Estimate75.76M23.97M102.65M75.95M
Year Ago Sales12.84M10.42M88.27M100.04M
Sales Growth (year/est)469.40%130.10%13.30%-32.10%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.14-0.18-0.38-0.48
EPS Actual-0.09-0.26-0.28-0.44
Difference0.05-0.080.10.04
Surprise %35.70%-44.40%26.30%8.30%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate2.120.171.14-0.91
7 Days Ago2.120.171.14-0.91
30 Days Ago1.880.170.9-1.06
60 Days Ago1.880.170.9-1.06
90 Days Ago1.020.790-0.11
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesENTAIndustrySectorS&P 500
Current Qtr.2,455.60%N/AN/A0.15
Next Qtr.165.40%N/AN/A0.27
Current Year0.90%N/AN/A0.07
Next Year-179.80%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)-20.77%N/AN/AN/A